ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 29 filers reported holding ATYR PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,367 | -99.9% | 624,000 | +26.7% | 2.16% | +14.0% |
| Q3 2022 | $1,478,000 | +16.8% | 492,500 | +10.2% | 1.89% | +26.4% |
| Q2 2022 | $1,265,000 | -16.3% | 447,000 | +58.3% | 1.50% | -37.2% |
| Q1 2022 | $1,511,000 | +14.4% | 282,420 | +59.8% | 2.38% | +40.2% |
| Q4 2021 | $1,321,000 | -12.0% | 176,782 | +6.9% | 1.70% | -15.9% |
| Q3 2021 | $1,501,000 | +71.5% | 165,318 | -7.8% | 2.02% | +68.2% |
| Q2 2021 | $875,000 | +66.3% | 179,308 | +51.7% | 1.20% | +102.2% |
| Q1 2021 | $526,000 | – | 118,220 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |